BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10917953)

  • 1. Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization.
    Riley RD; Sato H; Zhao ZQ; Thourani VH; Jordan JE; Fernandez AX; Ma XL; Hite DR; Rigel DF; Pellas TC; Peppard J; Bill KA; Lappe RW; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):350-8. PubMed ID: 10917953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence.
    Jordan JE; Zhao ZQ; Sato H; Taft S; Vinten-Johansen J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):301-9. PubMed ID: 8996210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model.
    Muraki S; Morris CD; Budde JM; Zhao ZQ; Guyton RA; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2003 Jan; 125(1):155-64. PubMed ID: 12538999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction.
    Tofukuji M; Stahl GL; Agah A; Metais C; Simons M; Sellke FW
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):1060-8. PubMed ID: 9832699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest.
    Khan TA; Bianchi C; Voisine P; Feng J; Baker J; Hart M; Takahashi M; Stahl G; Sellke FW
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):602-8. PubMed ID: 15457162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental off-pump coronary artery revascularization with adenosine-enhanced reperfusion.
    Muraki S; Morris CD; Budde JM; Velez DA; Zhao ZQ; Guyton RA; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2001 Mar; 121(3):570-9. PubMed ID: 11241093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of experimental canine myocardial infarct size with prostaglandin E1: inhibition of neutrophil migration and activation.
    Simpson PJ; Mickelson J; Fantone JC; Gallagher KP; Lucchesi BR
    J Pharmacol Exp Ther; 1988 Feb; 244(2):619-24. PubMed ID: 2831348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion.
    Liu X; Huang Y; Pokreisz P; Vermeersch P; Marsboom G; Swinnen M; Verbeken E; Santos J; Pellens M; Gillijns H; Van de Werf F; Bloch KD; Janssens S
    J Am Coll Cardiol; 2007 Aug; 50(8):808-17. PubMed ID: 17707188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of serotonin (5HT2) receptor blockade in myocardial reperfusion injury: effects of LY53857 in a canine model of myocardial infarction.
    Simpson PJ; Schelm JA; Jakubowski JA; Smallwood JK
    J Pharmacol Exp Ther; 1991 Sep; 258(3):979-85. PubMed ID: 1653847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass.
    Khan TA; Ruel M; Bianchi C; Voisine P; Komjáti K; Szabo C; Sellke FW
    J Am Coll Surg; 2003 Aug; 197(2):270-7. PubMed ID: 12892811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusion.
    Aversano T; Zhou W; Nedelman M; Nakada M; Weisman H
    J Am Coll Cardiol; 1995 Mar; 25(3):781-8. PubMed ID: 7860929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion.
    Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH
    J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.
    Halkos ME; Kerendi F; Corvera JS; Wang NP; Kin H; Payne CS; Sun HY; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Ann Thorac Surg; 2004 Sep; 78(3):961-9; discussion 969. PubMed ID: 15337028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of neutrophil adherence improves postischemic ventricular performance of the neonatal heart.
    Wilson I; Gillinov AM; Curtis WE; DiNatale J; Burch RM; Gardner TJ; Cameron DE
    Circulation; 1993 Nov; 88(5 Pt 2):II372-9. PubMed ID: 8222181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.
    Amsterdam EA; Stahl GL; Pan HL; Rendig SV; Fletcher MP; Longhurst JC
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H448-57. PubMed ID: 7840295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular unloading with intra-aortic counter pulsation prior to reperfusion reduces myocardial release of endothelin-1 and decreases infarction size in a porcine ischemia-reperfusion model.
    LeDoux JF; Tamareille S; Felli PR; Amirian J; Smalling RW
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):513-21. PubMed ID: 18814226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion.
    Zhao ZQ; Nakamura M; Wang NP; Velez DA; Hewan-Lowe KO; Guyton RA; Vinten-Johansen J
    J Surg Res; 2000 Dec; 94(2):133-44. PubMed ID: 11104653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury.
    Sato H; Zhao ZQ; McGee DS; Williams MW; Hammon JW; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 1995 Aug; 110(2):302-14. PubMed ID: 7543634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term inhibition of myocardial infarction by postconditioning during reperfusion.
    Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.